通过保护肝脏来对抗肌萎缩侧索硬化?一项前瞻性队列研究
该研究基于英国生物银行533707名参与者,评估肝病及磁共振成像衍生的铁校正T1映射(cT1)与肌萎缩侧索硬化(ALS)发病风险的关系。在中位随访5.6年的33959名有完整肝脏影像数据者中观察到15例新发ALS,肝病与ALS风险升高相关(调整后HR 7.35,95%CI 4.47-12.09,p<0.001),cT1每增加1个标准差与ALS风险升高相关(调整后HR 3.15,95%CI 1.79-5.55)。作者认为以cT1表示的肝病活动增加ALS发病风险,独立于代谢综合征、肝脂肪或纤维化。
要点
- 肝病与ALS发病风险升高相关,调整后HR 7.35(95%CI 4.47-12.09;p<0.001)。
- cT1每增加1个标准差,ALS风险升高,调整后HR 3.15(95%CI 1.79-5.55)。
- cT1与ALS风险的关联独立于代谢综合征、肝脂肪或纤维化。
核心结论
- 以cT1表示的肝病活动增加ALS发病风险,独立于代谢综合征、肝脂肪或纤维化。
研究设计与样本
- 前瞻性队列研究,基于英国生物银行533707名参与者,其中33959名有完整肝脏影像数据。
- 使用LiverMultiScan®软件测量并自动分析cT1和质子密度脂肪分数,基于年龄和血液标志物计算Fibrosis-4指数。
- 采用Cox比例风险模型分析肝病、肝脏生物标志物与新发ALS的关系。
主要发现
- 在533707名参与者中,28328名肝病患者随访期间发现24例ALS。
- 在33959名有完整肝脏影像数据者中,中位随访5.6年期间观察到15例新发ALS。
- 肝病患者发生ALS的风险更高,调整后HR 7.35(95%CI 4.47-12.09;p<0.001)。
- 调整年龄、性别、Townsend剥夺指数、吸烟状态、饮酒频率、体重指数、质子密度脂肪分数、Fibrosis-4和代谢综合征后,cT1每增加1个标准差与ALS风险升高显著相关,调整后HR 3.15(95%CI 1.79-5.55)。
- 敏感性分析证实这些结果稳健。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Previous studies have observed liver abnormalities in amyotrophic lateral sclerosis (ALS) patients. This study aimed to investigate whether early signs of liver disease, measured by magnetic resonance imaging-derived iron-corrected T1-mapping (cT1), are risk factors for developing ALS. METHODS: cT1 and proton density fat fraction were measured and automatically analyzed using LiverMultiScan® software. The Fibrosis-4 index was calculated using an established formula based on age and blood markers. Cox proportional hazard models were used to examine the relationship between liver disease, liver biomarkers, and incident ALS. RESULTS: In a cohort of 533,707 individuals from UK Biobank, 24 ALS cases were identified among 28,328 participants with liver disease during the follow-up period. Among a total of 33,959 individuals with complete liver imaging data, 15 incident ALS cases were observed during a median follow-up period of 5.6 years. Individuals with liver disease had a higher risk of developing ALS, with an adjusted hazard ratio of 7.35 (95% CI 4.47-12.09; p < 0.001). An increase in cT1 was also associated with a higher risk of ALS. After adjusting for age, sex, Townsend deprivation index, smoking status, alcohol intake frequency, body mass index, proton density fat fraction, Fibrosis-4, and metabolic syndrome, an increase in cT1 remained significantly associated with a higher risk of ALS, with an adjusted hazard ratio of 3.15 (95% CI 1.79-5.55) per 1-SD increase. Sensitivity analyses confirmed these robust results. INTERPRETATION: Liver disease activity, indicated by cT1, increases the risk of developing ALS, independent of metabolic syndrome, liver fat, or fibrosis. ANN NEUROL 2025;97:270-280.
引用
- Zhu L, Li Y, Yu X, et al. Fighting Amyotrophic Lateral Sclerosis by Protecting the Liver? A Prospective Cohort Study. Ann Neurol. 2024. PMID: 39425590. doi:10.1002/ana.27115
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。